Description Port Therapeutics is a stealth venture-backed biotechnology company launched by co-founders Gabe Kwong (Georgia Tech), Mikhail Shapiro (Caltech, HHMI) and Sangeeta Bhatia (MIT, HHMI). Port Therapeutics was founded with the vision to merge breakthrough advances in synthetic biology, cell engineering, and radiation oncology to enable safer, more precise and potent therapies. The company’s platform technology will allow physicians to deliver the right therapy, at the right place, at the right time to meaningfully improve the outcome of patients with serious diseases such as cancer.